NASDAQ · CTEV
Healthcare · Medical - Healthcare Information Services
$31.73
Down-$1.83 (-5.45%)
Updated Sep 18, 2026, 2:17 AM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
CTEV closed at $33.56 after 19 trading sessions, down 1.53% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $35.24 | $35.67 | $33.50 | $33.56 | 99.13K |
| Sep 15, 2026 | $36.08 | $36.465 | $34.19 | $35.54 | 116.36K |
| Sep 14, 2026 | $35.66 | $37.28 | $35.66 | $36.44 | 126.87K |
| Sep 11, 2026 | $37.23 | $37.57 | $33.87 | $35.98 | 153.68K |
| Sep 10, 2026 | $35.35 | $37.77 | $35.2279 | $36.74 | 82.88K |
| Sep 9, 2026 | $37.71 | $37.71 | $35.655 | $36.29 | 119.2K |
| Sep 8, 2026 | $37.77 | $38.5806 | $36.41 | $37.71 | 94.93K |
| Sep 4, 2026 | $39.08 | $39.08 | $37.66 | $38.43 | 70.57K |
| Sep 3, 2026 | $40.46 | $42.00 | $38.52 | $39.09 | 83.85K |
| Sep 2, 2026 | $38.86 | $40.29 | $36.99 | $40.23 | 117.65K |
| Sep 1, 2026 | $39.43 | $40.82 | $38.83 | $39.35 | 134.83K |
| Aug 31, 2026 | $41.05 | $41.68 | $38.9562 | $39.83 | 139.41K |
| Aug 28, 2026 | $38.06 | $39.6463 | $37.85 | $39.39 | 132.98K |
| Aug 27, 2026 | $37.47 | $39.79 | $37.47 | $38.78 | 155.27K |
| Aug 26, 2026 | $37.58 | $37.63 | $36.855 | $37.57 | 63.91K |
| Aug 25, 2026 | $36.64 | $38.85 | $35.68 | $37.64 | 139.86K |
| Aug 24, 2026 | $37.53 | $38.3982 | $36.29 | $36.58 | 76.19K |
| Aug 21, 2026 | $34.25 | $37.34 | $34.25 | $37.27 | 199.24K |
| Aug 20, 2026 | $35.00 | $35.00 | $33.9205 | $34.08 | 94.41K |
The latest Smart Investors Daily articles mentioning CTEV.
CTEV research
Company profile and research snapshot.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 21, 2026 | Barclays | Overweight | — |
| Aug 12, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 10, 2026 | Citigroup | Buy | — |
| Aug 10, 2026 | Canaccord Genuity | Buy | — |
| Jul 21, 2026 | Canaccord Genuity | Buy | — |
Generated Sep 17, 2026, 9:20 PM
Claritev Corporation shares declined 5.45% today, falling $1.83 despite the company presenting at the Morgan Stanley Global Healthcare Conference and announcing a board appointment. The sell-off appears disconnected from the announced corporate developments, suggesting broader market headwinds or profit-taking may be driving the weakness.
Bottom line: CTEV's significant decline today despite announcing board leadership additions and presenting at a major healthcare conference suggests market skepticism about the company's near-term catalysts or valuation. Investors should review the full Morgan Stanley presentation transcript to assess whether the company provided sufficient forward-looking guidance and strategic clarity to justify renewed confidence.
SeekingAlpha · Sep 15, 2026
Claritev Corporation (CTEV) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 9:15 AM EDTCompany ParticipantsTravis Dalton - CEO,...
Yahoo · Sep 15, 2026
MCLEAN, Va., September 15, 2026--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data, and insights company, today announced that its Board of Directors ("Board") has appointed Ben Letham as a director, effective September 14, 2026, to fill a vacancy on the Board. Letham’s extensive experience in artificial intelligence (AI) will enhance the Board’s depth of expertise and support the Company’s long-term strategic objectives.
Yahoo · Sep 10, 2026
MCLEAN, Va., September 10, 2026--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable and transparent for all, today announced that Claritev Cares, its nonprofit foundation focused on expanding access to healthcare, has awarded its 2026 Rural Health Grants to Fairfield Memorial Hospital in Fairfield, Illinois, and Kodiak Community Health Center in Kodiak, Alaska.
Yahoo · Sep 8, 2026
On August 7, Claritev Corporation (NYSE:CTEV) reported second-quarter results that beat its own targets, marking five consecutive quarters of year-over-year revenue growth. Revenue for the quarter ended June 30 climbed 6.6% to $257.5 million, and management used the momentum to raise full-year guidance for the second time this year. The number that matters most, though, […]
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CTEV.
